Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

von Morris, MJ ; Castellano, D ; Herrmann, K ; et al.

Schlagworte: Humans; Male; Prostatic Neoplasms; Castration-Resistant; Heterocyclic Compounds; 1-Ring; Aged; Lutetium; Androstenes; Dipeptides; Phenylthiohydantoin; Nitriles; Androgen Receptor Antagonists; Middle Aged; Benzamides; Taxoids; Prostate-Specific Antigen; Radioisotopes; Progression-Free Survival

• View full text via BASE

von Agarwal, N ; Saad, F ; Azad, AA ; et al.

• View full text via BASE

von Steinberg, GD ; Shore, ND ; Redorta, JP ; et al.

Schlagworte: BCG; Bacillus Calmette-Guérin; NMIBC; PD-1; PD-L1; bladder cancer; immune checkpoint inhibitor; immunotherapy; non-muscle-invasive bladder cancer; sasanlimab; Humans; Administration; Intravesical; BCG Vaccine; Clinical Trials; Phase III as Topic; Immune Checkpoint Inhibitors; Neoplasm Invasiveness; Neoplasm Recurrence; Local; Non-Muscle Invasive Bladder Neoplasms; Progression-Free Survival; Randomized Controlled Trials as Topic; Urinary Bladder Neoplasms

• View full text via BASE

von Armstrong, AJ ; Azad, AA ; Iguchi, T ; et al.

• View full text via BASE

von Dearnaley, DP ; Saltzstein, DR ; Sylvester, JE ; et al.

• View full text via BASE

von Shore, ND ; Khan, N ; McKay, RR ; et al.

Value in Health ; volume 27, issue 12, page S20 ; ISSN 1098-3015

• Volltextverfügbarkeit prüfen (via ReDI)

von Giri, VN ; Knudsen, KE ; Kelly, WK ; et al.

Giri, VN, Knudsen, KE, Kelly, WK, Abida, W, Andriole, GL, Bangma, C H, Bekelman, JE, Benson, MC, Blanco, A, Burnett, A, Catalona, WJ, Cooney, KA, Cooperberg, M, Crawford, DE, Den, RB, Dicker, AP, Eggener, S, Fleshner, N, Freedman, ML, Hamdy, FC, Hoffman-Censits, J, Hurwitz, MD, Hyatt, C, Isaacs, WB, Kane, CJ, Kantoff, P, Karnes, RJ, Karsh, LI, Klein, EA, Lin, DW, Loughlin, KR, Lu-Yao, G, Malkowicz, SB, Mann, MJ, Mark, JR, McCue, PA, Miner, MM, Morgan, T, Moul, JW, Myers, RE, Nielsen, SM, Obeid, E, Pavlovich, CP, Peiper, SC, Penson, DF, Petrylak, D, Pettaway, CA, Pilarski, R, Pinto, PA, ....

Schlagworte: /dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM034901; name=EMC MM-03-49-01; /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; name=SDG 3 - Good Health and Well-being

• View full text via BASE

von Armstrong, AJ ; Saad, F ; Phung, D ; et al.

Schlagworte: Humans; Carcinoma; Taxoids; Phenylthiohydantoin; Kallikreins; Prostate-Specific Antigen; Antineoplastic Agents; Disease-Free Survival; Treatment Outcome; Survival Rate; Proportional Hazards Models; Double-Blind Method; Male; Kaplan-Meier Estimate; Prostatic Neoplasms; Castration-Resistant; Docetaxel

• View full text via BASE

von de Bono, JS ; Smith, MR ; Saad, F ; et al.

Schlagworte: Humans; Carcinoma; Neoplasm Metastasis; Taxoids; Prednisone; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Survival Rate; Age Factors; Adult; Aged; 80 and over; Middle Aged; Male; Prostatic Neoplasms; Castration-Resistant; Practice Patterns; Physicians'; Abiraterone Acetate; Docetaxel

• View full text via BASE

von Shore ND ; Saad F ; Cookson MS ; et al.

• Volltextverfügbarkeit prüfen (via ReDI)

von Ravaud A ; Motzer RJ ; Pandha HS ; et al.

Schlagworte: Adolescent; Adult; Aged; 80 and over; Antineoplastic Agent; Carcinoma; Renal Cell; Chemotherapy; Adjuvant; Double-Blind Method; Drug Administration Schedule; Female; Human; Indole; Kidney Neoplasm; Male; Middle Aged; Pyrrole; Survival Analysi; Young Adult; Nephrectomy; Medicine (all)

• Volltextverfügbarkeit prüfen (via ReDI)

von Saad, Fred ; Matsubara, Nobuaki ; Agarwal, Neeraj ; et al.

Scientia

Schlagworte: Quimioteràpia combinada; Metàstasi; Pròstata - Càncer - Tractament; ANALYTICAL; DIAGNOSTIC AND THERAPEUTIC TECHNIQUES; AND EQUIPMENT::Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols; DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms; Male::Prostatic Neoplasms::Prostatic Neoplasms; Castration-Resistant; Other subheadings::Other subheadings::Other subheadings::/drug therapy; AND EQUIPMENT::Investigative Techniques::Methods::Research Design; TÉCNICAS Y EQUIPOS ANALÍTICOS; DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada; ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales masculinos::neoplasias de la próstata::neoplasias prostáticas resistentes a la castración; Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia; DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos::diseño de la investigación

• View full text via BASE

von Gillessen, S ; Turco, F ; Davis, ID ; et al.

Advanced Prostate Cancer Consensus Conference 2024

Schlagworte: Conference Paper

• Zum Volltext über OAIster